ResMed (RMD) Tops Q3 EPS by 5c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $210.98 --0%
Revenue Growth %: +13.1%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
ABTC, DEA, LIFE, More
Revenue Growth %: +13.1%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
ABTC, DEA, LIFE, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $2.86, $0.05 better than the analyst estimate of $2.81. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.42 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Atkore Inc (ATKR) Tops Q3 EPS by 14c
- UBS Downgrades Stellantis NV (STLA:IM) (STLA) to Neutral
- Safehold (SAFE) Reiterated at Market Outperform by Citizens Despite EPS Estimate Cut
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
